Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_assertion type Assertion NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_head.
- NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_assertion description "[Taken together, these data provide proof of principle that the progesterone receptor of myelin-forming Schwann cells is a promising pharmacological target for therapy of CMT-1A.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_provenance.
- NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_assertion evidence source_evidence_literature NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_provenance.
- NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_assertion SIO_000772 14608378 NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_provenance.
- NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_assertion wasDerivedFrom befree-2016 NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_provenance.
- NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_assertion wasGeneratedBy ECO_0000203 NP419992.RA-qYyVA1xTbezHjstckEhDuTPvWjjRLoIFGpcL2wGQ4g130_provenance.